Читать книгу Anterior Skull Base Tumors - Группа авторов - Страница 72

1El-Naggar AK: Editor’s perspective on the 4th edition of the WHO head and neck tumor classification. J Egypt Natl Cancer 2017;29:65–66.

2Llorente JL, Lopez F, Suarez C, Hermsen MA: Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol 2014;11:460–472.

3Youlden DR, Cramb SM, Peters S, et al: International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol 2013;37:770–779.

4Robin PE, Powell DJ, Stansbie JM: Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological types. Clin Otolaryngol Allied Sci 1979;4:431–456.

5Sanghvi S, Khan MN, Patel NR, Yeldandi S, Baredes S, Eloy JA: Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4,994 patients. Laryngoscope 2014;124:76–83.

6Turner JH, Reh DD: Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 2012;34:877–885.

7Jeng YM, Sung MT, Fang CL, et al: Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol 2002;26:371–376.

8Zong Y, Liu K, Zhong B, Chen G, Wu W: Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou. Chin Med J 2001;114:132–136.

9Rytkonen AE, Hirvikoski PP, Salo TA: Lymphoepithelial carcinoma: two case reports and a systematic review of oral and sinonasal cases. Head Neck Pathol 2011;5:327–334.

10Wenig BM: Lymphoepithelial-like carcinomas of the head and neck. Semin Diagn Pathol 2015;32:74–86.

11Reiersen DA, Pahilan ME, Devaiah AK: Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg 2012;147:7–14.

12Chambers KJ, Lehmann AE, Remenschneider A, et al: Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. J Neurol Surg B Skull Base 2015;76:94–100.

13Chernock RD, Perry A, Pfeifer JD, Holden JA, Lewis JS Jr: Receptor tyrosine kinases in sinonasal undifferentiated carcinomas – evaluation for EGFR, c-KIT, and HER2/neu expression. Head Neck 2009;31:919–927.

14Gray ST, Herr MW, Sethi RK, et al: Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head Neck 2015;37:366–374.

15Bossi P, Saba NF, Vermorken JB, et al: The role of systemic therapy in the management of sinonasal cancer: a critical review. Cancer Treat Rev 2015;41:836–843.

16Yoshida E, Aouad R, Fragoso R, et al: Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck. Am J Otolaryngol 2013;34:658–663.

17Bauer DE, Mitchell CM, Strait KM, et al: Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 2012;18:5773–5779.

18Chau NG, Mitchell CM, Aserlind A, et al: Aggressive treatment and survival outcomes in NUT midline carcinoma (NMC) of the head and neck (HN). J Clin Oncol 2014;32:6057.

19Solomon LW, Magliocca KR, Cohen C, Muller S: Retrospective analysis of nuclear protein in testis (NUT) midline carcinoma in the upper aerodigestive tract and mediastinum. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:213–220.

20Rutt AL, Poulik J, Siddiqui AH, et al: NUT midline carcinoma mimicking tonsillitis in an eight-year-old girl. Ann Otol Rhinol Laryngol 2011;120:546–549.

21Haack H, Johnson LA, Fry CJ, et al: Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009;33:984–991.

22French CA: Pathogenesis of NUT midline carcinoma. Annu Rev Pathol 2012;7:247–265.

23French CA, Kutok JL, Faquin WC, et al: Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22:4135–4139.

24Suzuki S, Kurabe N, Ohnishi I, et al: NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue. Pathol Res Pract 2015;211:404–408.

25Patel TD, Vazquez A, Dubal PM, Baredes S, Liu JK, Eloy JA: Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival. Int Forum Allergy Rhinol 2015;5:448–453.

26Smith SR, Som P, Fahmy A, Lawson W, Sacks S, Brandwein M: A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope 2000;110:1617–1622.

27Chai L, Ying HF, Wu TT, et al: Clinical features and hypoxic marker expression of primary sinonasal and laryngeal small-cell neuroendocrine carcinoma: a small case series. World J Surg Oncol 2014;12:199.

28Mitchell EH, Diaz A, Yilmaz T, et al: Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck 2012;34:1372–1376.

29Su SY, Bell D, Hanna EY: Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol 2014;18(suppl 2):S149–S156.

30Babin E, Rouleau V, Vedrine PO, et al: Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol 2006;120:289–297.

31Likhacheva A, Rosenthal DI, Hanna E, Kupferman M, Demonte F, El-Naggar AK: Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol 2011;3:32.

32Vasan NR, Medina JE, Canfield VA, Gillies EM: Sinonasal neuroendocrine carcinoma in association with SIADH. Head Neck 2004;26:89–93.

33Weinreb I, Perez-Ordonez B: Non-small cell neuroendocrine carcinoma of the sinonasal tract and nasopharynx. Report of 2 cases and review of the literature. Head Neck Pathol 2007;1:21–26.

34Salem F, Rosenblum MK, Jhanwar SC, Kancherla P, Ghossein RA, Carlson DL: Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status. Hum Pathol 2008;39:605–609.

35Vranic S, Caughron SK, Djuricic S, et al: Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literature. BMC Ear Nose Throat Disord 2008;8:8.

36Misra P, Husain Q, Svider PF, Sanghvi S, Liu JK, Eloy JA: Management of sinonasal teratocarcinosarcoma: a systematic review. Am J Otolaryngol 2014;35:5–11.

37Barnes L: Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986;10:192–202.

38Kleinsasser O, Schroeder HG: Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otorhinolaryngol 1988;245:1–15.

39Sanchez-Casis G, Devine KD, Weiland LH: Nasal adenocarcinomas that closely simulate colonic carcinomas. Cancer 1971;28:714–720.

40Hadfield EH, Macbeth RG: Adenocarcinoma of ethmoids in furniture workers. Ann Otol Rhinol Laryngol 1971;80:699–703.

41Luce D, Leclerc A, Begin D, et al: Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control 2002;13:147–157.

42Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B: Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004;57:932–937.

43McKinney CD, Mills SE, Franquemont DW: Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol 1995;8:421–426.

44Buchwald C, Franzmann MB, Tos M: Sinonasal papillomas: a report of 82 cases in Copenhagen County, including a longitudinal epidemiological and clinical study. Laryngoscope 1995;105:72–79.

45Nudell J, Chiosea S, Thompson LD: Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol 2014;8:269–286.

46Kim DY, Hong SL, Lee CH, et al: Inverted papilloma of the nasal cavity and paranasal sinuses: a Korean multicenter study. Laryngoscope 2012;122:487–494.

47Vorasubin N, Vira D, Suh JD, Bhuta S, Wang MB: Schneiderian papillomas: comparative review of exophytic, oncocytic, and inverted types. Am J Rhinol Allergy 2013;27:287–292.

48Kuan EC, Diaz MF, Chiu AG, Bergsneider M, Wang MB, Suh JD: Sinonasal and skull base pleomorphic adenoma: a case series and literature review. Int Forum Allergy Rhinol 2015;5:460–468.

49Cimino-Mathews A, Lin BM, Chang SS, Boahene KD, Bishop JA: Carcinoma ex pleomorphic adenoma of the nasal cavity. Head Neck Pathol 2011;5:405–409.

50Spiro RH, Koss LG, Hajdu SI, Strong EW: Tumors of minor salivary origin. A clinicopathologic study of 492 cases. Cancer 1973;31:117–129.

51Patel TD, Carniol ET, Vazquez A, Baredes S, Liu JK, Eloy JA: Sinonasal fibrosarcoma: analysis of the Surveillance, Epidemiology, and End Results database. Int Forum Allergy Rhinol 2016;6:201–205.

52Cai PQ, Wu YP, Li L, et al: CT and MRI of radiation-induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin Radiol<italic></italic>2013;68:683–689.

53Fu YS, Perzin KH: Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. VI. Fibrous tissue tumors (fibroma, fibromatosis, fibrosarcoma). Cancer 1976;37:2912–2928.

54Guillou L, Aurias A: Soft tissue sarcomas with complex genomic profiles. Virchows Arch 2010;456:201–217.

55Huang HY, Antonescu CR: Sinonasal smooth muscle cell tumors: a clinicopathologic and immunohistochemical analysis of 12 cases with emphasis on the low-grade end of the spectrum. Arch Pathol Lab Med 2003;127:297–304.

56Schutz A, Smeets R, Driemel O, et al: Primary and secondary leiomyosarcoma of the oral and perioral region – clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature. J Oral Maxillofac Surg 2013;71:1132–1142.

57Dry SM, Jorgensen JL, Fletcher CD: Leiomyosarcomas of the oral cavity: an unusual topographic subset easily mistaken for nonmesenchymal tumours. Histopathology 2000;36:210–220.

58Callender TA, Weber RS, Janjan N, et al: Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 1995;112:252–257.

59Sanghvi S, Misra P, Patel NR, Kalyoussef E, Baredes S, Eloy JA: Incidence trends and long-term survival analysis of sinonasal rhabdomyosarcoma. Am J Otolaryngol 2013;34:682–689.

60Szablewski V, Neuville A, Terrier P, et al: Adult sinonasal soft tissue sarcoma: analysis of 48 cases from the French Sarcoma Group database. Laryngoscope<italic></italic>2015;125:615–623.

61Hicks J, Flaitz C: Rhabdomyosarcoma of the head and neck in children. Oral Oncol 2002;38:450–459.

62Nascimento AF, Fletcher CD: Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol 2005;29:1106–1113.

63Yasuda T, Perry KD, Nelson M, et al: Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol 2009;40:341–348.

64Mosquera JM, Sboner A, Zhang L, et al: Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer 2013;52:538–550.

65Thompson CF, Kim BJ, Lai C, et al: Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes. Int Forum Allergy Rhinol 2013;3:678–683.

66Wurm J, Constantinidis J, Grabenbauer GG, Iro H: Rhabdomyosarcomas of the nose and paranasal sinuses: treatment results in 15 cases. Otolaryngol Head Neck Surg 2005;133:42–50.

67Fletcher CDM BJ, Hogendoorn PCW, Mertens F: WHO Classification of Tumours of Soft Tissue and Bone. Lyon, IARC, 2013.

68Kerouanton A, Jimenez I, Cellier C, et al: Synovial sarcoma in children and adolescents. J Pediatr Hematol Oncol 2014;36:257–262.

69Fisher C: Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch 2010;456:153–166.

70Thway K, Fisher C: Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol 2014;18:369–380.

71Vlenterie M, Jones RL, van der Graaf WT: Synovial sarcoma diagnosis and management in the era of targeted therapies. Curr Opin Oncol 2015;27:316–322.

72Przybyl J, Sciot R, Wozniak A, et al: Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features. Int J Biochem Cell Biol 2014;53:505–513.

73Nelson BL, Thompson LD: Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature. Head Neck Pathol 2007;1:1–12.

74Maddox JC, Evans HL: Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer 1981;48:1907–1921.

75Narula AA, Vallis MP, el-Silimy OE, Dowling F, Bradley PJ: Radiation induced angiosarcomas of the nasopharynx. Eur J Surg Oncol 1986;12:147–152.

76Wong KF, So CC, Wong N, Siu LL, Kwong YL, Chan JK: Sinonasal angiosarcoma with marrow involvement at presentation mimicking malignant lymphoma: cytogenetic analysis using multiple techniques. Cancer Genet Cytogenet 2001;129:64–68.

77Fu YS, Perzin KH: Non-epithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: a clinicopathologic study. I. General features and vascular tumors. Cancer 1974;33:1275–1288.

78Sekhar LN, Pranatartiharan R, Chanda A, Wright DC: Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg Focus 2001;10:E2.

79Korten AG, ter Berg HJ, Spincemaille GH, van der Laan RT, Van de Wel AM: Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry 1998;65:88–92.

80Rapidis AD, Archondakis G, Anteriotis D, Skouteris CA: Chondrosarcomas of the skull base: review of the literature and report of two cases. J Craniomaxillofac Surg 1997;25:322–327.

81Panda NK, Jain A, Eshwara Reddy CE: Osteosarcoma and chondrosarcoma of the maxilla. Br J Oral Maxillofac Surg 2003;41:329–333.

82Whitehead RE, Melhem ER, Kasznica J, Eustace S: Telangiectatic osteosarcoma of the skull base. AJNR Am J Neuroradiol 1998;19:754–757.

83Huang SC, Ghossein RA, Bishop JA, et al: Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol 2016;40:51–59.

84Lewis JT, Oliveira AM, Nascimento AG, et al: Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol 2012;36:517–525.

85Powers KA, Han LM, Chiu AG, Aly FZ: Low-grade sinonasal sarcoma with neural and myogenic features – diagnostic challenge and pathogenic insight. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:e265–e269.

86Wang X, Bledsoe KL, Graham RP, et al: Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 2014;46:666–668.

87Wong WJ, Lauria A, Hornick JL, Xiao S, Fletcher JA, Marino-Enriquez A: Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes Cancer 2016;55:25–29.

88Sumegi J, Streblow R, Frayer RW, et al: Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 2010;49:224–236.

89Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE: Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol 2006;30:811–818.

90St Martin M, Levine SC: Chordomas of the skull base: manifestations and management. Curr Opin Otolaryngol Head Neck Surg 2003;11:324–327.

91Hug EB: Review of skull base chordomas: prognostic factors and long-term results of proton-beam radiotherapy. Neurosurg Focus 2001;10:E11.

92DeMonte F, Diaz E Jr, Callender D, Suk I: Transmandibular, circumglossal, retropharyngeal approach for chordomas of the clivus and upper cervical spine. Technical note. Neurosurg Focus 2001;10:E10.

93Colli BO, Al-Mefty O: Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 2001;10:E1.

94Dehner LP, Askin FB: Tumors of fibrous tissue origin in childhood. A clinicopathologic study of cutaneous and soft tissue neoplasms in 66 children. Cancer 1976;38:888–900.

95Pena S, Brickman T, StHilaire H, Jeyakumar A: Aggressive fibromatosis of the head and neck in the pediatric population. Int J Pediatr Otorhinolaryngol 2014;78:1–4.

96Colombo C, Miceli R, Lazar AJ, et al: CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer 2013;119:3696–3702.

97van Broekhoven DL, Verhoef C, Grunhagen DJ, et al: Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 2015;22:1464–1470.

98Mentzel T, Beham A, Calonje E, Katenkamp D, Fletcher CD: Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol 1997;21:363–374.

99Weiss SW, Enzinger FM: Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970–981.

100Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, et al: Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol 2014;9:131.

101Tanas MR, Sboner A, Oliveira AM, et al: Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 2011;3:98ra82.

102Deyrup AT, Tighiouart M, Montag AG, Weiss SW: Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol 2008;32:924–927.

103Friedman CD, Costantino PD, Teitelbaum B, Berktold RE, Sisson GA Sr: Primary extracranial meningiomas of the head and neck. Laryngoscope 1990;100:41–48.

104Shibuya M: Pathology and molecular genetics of meningioma: recent advances. Neurol Med Chir (Tokyo) 2015;55:14–27.

105Thompson LD, Gyure KA: Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol 2000;24:640–650.

106Ho KL: Primary meningioma of the nasal cavity and paranasal sinuses. Cancer<italic></italic>1980;46:1442–1447.

107Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;17:2683–2706.

108Jethanamest D, Morris LG, Sikora AG, Kutler DI: Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276–280.

109Platek ME, Merzianu M, Mashtare TL, et al: Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol 2011;6:41.

110Mills SE: Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 2002;15:264–278.

111Thompson LD: Olfactory neuroblastoma. Head Neck Pathol 2009;3:252–259.

112Saade RE, Hanna EY, Bell D: Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep 2015;17:423.

113Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB: Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg 2014;140:1124–1129.

114Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J: Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer 2013;49:1324–1334.

115Hafezi S, Seethala RR, Stelow EB, et al: Ewing’s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol 2011;5:8–16.

116Holsinger FC, Hafemeister AC, Hicks MJ, Sulek M, Huh WW, Friedman EM: Differential diagnosis of pediatric tumors of the nasal cavity and paranasal sinuses: a 45-year multi-institutional review. Ear Nose Throat J 2010;89:534–540.

117Whaley JT, Indelicato DJ, Morris CG, et al: Ewing tumors of the head and neck. Am J Clin Oncol 2010;33:321–326.

118Balatsouras DG, Eliopoulos PN, Economou CN: Multiple glomus tumours. J Laryngol Otol<italic></italic>1992;106:538–543.

119Woodruff JM, Huvos AG, Erlandson RA, Shah JP, Gerold FP: Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol 1985;9:771–790.

120Lack EE, Cubilla AL, Woodruff JM: Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients. Hum Pathol 1979;10:191–218.

121Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ: Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol 2001;25:782–787.

122Thompson LD, Wieneke JA, Miettinen M: Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594–611.

123Hodi FS, Corless CL, Giobbie-Hurder A, et al: Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol 2013;31:3182–3190.

124Turri-Zanoni M, Medicina D, Lombardi D, et al: Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck 2013;35:1066–1077.

125Lazarev S, Gupta V, Hu K, Harrison LB, Bakst R: Mucosal melanoma of the head and neck: a systematic review of the literature. Int J Radiat Oncol Biol Phys<italic></italic>2014;90:1108–1118.

126Lund VJ, Chisholm EJ, Howard DJ, Wei WI: Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 2012;50:203–210.

127Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD: Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg 2008;138:347–352.

128Bachar G, Loh KS, O’Sullivan B, et al: Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 2008;30:1325–1331.

129Rodriguez J, Romaguera JE, Manning J, et al: Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma 2000;39:139–144.

130Jaffe ES, Chan JK, Su IJ, et al: Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103–111.

131Abbondanzo SL, Wenig BM: Non-Hodgkin’s lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995;75:1281–1291.

132Kent SE, Majumdar B: Metastatic tumours in the maxillary sinus. A report of two cases and a review of the literature. J Laryngol Otol 1985;99:459–462.

133Flocks RH, Boatman DL: Incidence of head and neck metastases from genito-urinary neoplasms. Laryngoscope 1973;83:1527–1539.

Michelle Williams, MD

Department of Pathology, The University of Texas MD Anderson Cancer Center

1515 Holcombe Blvd, Unit 85

Houston, TX 77030 (USA)

E-Mail mdwillia@mdanderson.org